OFD1P11Y

Across TCGA pan-cancer cohorts, OFD1P11Y RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated OFD1P11Y data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OFD1P11Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OFD1P11Y expression acts as an unfavorable survival marker.

STAD, KIRP, and SARC are the cancer types where OFD1P11Y RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	III,IV	0.052	0.633	<.001	72	view →
KIRP	DFS	Tertile	All	0.123	0.605	.009	18	view →
SARC	DFS	Tertile	All	0.168	0.612	.013	18	view →
THCA	OS	Tertile	All	0.375	0.948	.007	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

OFD1P11Y–STAD (OS)

Open the STAD breakdown →